- Home
- NVNI vs TLPH Comparison
NVNI vs TLPH Comparison
Compare NVNI & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNI
- TLPH
- Stock Information
- Founded
- NVNI 2019
- TLPH 2005
- Country
- NVNI Brazil
- TLPH United States
- Employees
- NVNI N/A
- TLPH N/A
- Industry
- NVNI
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- NVNI
- TLPH Health Care
- Exchange
- NVNI Nasdaq
- TLPH Nasdaq
- Market Cap
- NVNI 57.2M
- TLPH 64.7M
- IPO Year
- NVNI N/A
- TLPH 2011
- Fundamental
- Price
- NVNI $2.92
- TLPH $1.33
- Analyst Decision
- NVNI
- TLPH Strong Buy
- Analyst Count
- NVNI 0
- TLPH 1
- Target Price
- NVNI N/A
- TLPH $6.00
- AVG Volume (30 Days)
- NVNI 107.3K
- TLPH 342.7K
- Earning Date
- NVNI 09-30-2025
- TLPH 11-12-2025
- Dividend Yield
- NVNI N/A
- TLPH N/A
- EPS Growth
- NVNI N/A
- TLPH N/A
- EPS
- NVNI N/A
- TLPH N/A
- Revenue
- NVNI $31,250,627.00
- TLPH $28,000.00
- Revenue This Year
- NVNI $12.05
- TLPH N/A
- Revenue Next Year
- NVNI $15.02
- TLPH $14,533.26
- P/E Ratio
- NVNI N/A
- TLPH N/A
- Revenue Growth
- NVNI 1491.58
- TLPH N/A
- 52 Week Low
- NVNI $1.44
- TLPH $0.38
- 52 Week High
- NVNI $121.90
- TLPH $1.57
- Technical
- Relative Strength Index (RSI)
- NVNI 45.29
- TLPH 53.41
- Support Level
- NVNI $2.80
- TLPH $1.28
- Resistance Level
- NVNI $3.07
- TLPH $1.57
- Average True Range (ATR)
- NVNI 0.25
- TLPH 0.13
- MACD
- NVNI -0.07
- TLPH -0.01
- Stochastic Oscillator
- NVNI 24.64
- TLPH 53.57
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.